JPMORGAN CHASE & CO - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 22 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q3 2023$1910
+66.7%
0.00%
Q3 2020$060.0%0.00%
Q2 2020$0
-100.0%
6
-99.8%
0.00%
Q3 2018$22,000
-64.5%
3,868
-53.8%
0.00%
Q4 2017$62,000
-34.0%
8,378
-54.6%
0.00%
Q2 2013$94,00018,4550.00%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q3 2023
NameSharesValueWeighting ↓
Sterling Financial Planning, Inc. 22,031$46,0000.03%
BERKSHIRE ASSET MANAGEMENT LLC/PA 189,048$392,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 286,655$595,0000.01%
Renaissance Technologies 622,228$1,291,0000.00%
ACADIAN ASSET MANAGEMENT LLC 188,164$390,0000.00%
Oakworth Capital, Inc. 3,052$6,0000.00%
BlackRock Inc. 140,248$292,0000.00%
Citadel Advisors 32,300$67,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 28,900$60,0000.00%
TWO SIGMA ADVISERS, LP 34,592$72,0000.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders